These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 28499633)

  • 1. Controllable release of nitric oxide and doxorubicin from engineered nanospheres for synergistic tumor therapy.
    Tan L; Huang R; Li X; Liu S; Shen YM
    Acta Biomater; 2017 Jul; 57():498-510. PubMed ID: 28499633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. pH-sensitive doxorubicin-conjugated prodrug micelles with charge-conversion for cancer therapy.
    Ma B; Zhuang W; Wang Y; Luo R; Wang Y
    Acta Biomater; 2018 Apr; 70():186-196. PubMed ID: 29452272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergistic dual-pH responsive copolymer micelles for pH-dependent drug release.
    Deng H; Zhao X; Liu J; Zhang J; Deng L; Liu J; Dong A
    Nanoscale; 2016 Jan; 8(3):1437-50. PubMed ID: 26677141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis of doxorubicin-PLGA loaded chitosan stabilized (Mn, Zn)Fe2O4 nanoparticles: Biological activity and pH-responsive drug release.
    Montha W; Maneeprakorn W; Buatong N; Tang IM; Pon-On W
    Mater Sci Eng C Mater Biol Appl; 2016 Feb; 59():235-240. PubMed ID: 26652369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Doxorubicin and adjudin co-loaded pH-sensitive nanoparticles for the treatment of drug-resistant cancer.
    Wang Q; Zou C; Wang L; Gao X; Wu J; Tan S; Wu G
    Acta Biomater; 2019 Aug; 94():469-481. PubMed ID: 31141733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chitosan-based core-shell nanomaterials for pH-triggered release of anticancer drug and near-infrared bioimaging.
    Tan L; Huang R; Li X; Liu S; Shen YM; Shao Z
    Carbohydr Polym; 2017 Feb; 157():325-334. PubMed ID: 27987935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Smart doxorubicin nanoparticles with high drug payload for enhanced chemotherapy against drug resistance and cancer diagnosis.
    Yu C; Zhou M; Zhang X; Wei W; Chen X; Zhang X
    Nanoscale; 2015 Mar; 7(13):5683-90. PubMed ID: 25740312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Near-Infrared Light-Triggered Drug Release from Ultraviolet- and Redox-Responsive Polymersome Encapsulated with Core-Shell Upconversion Nanoparticles for Cancer Therapy.
    Tsai MF; Lo YL; Soorni Y; Su CH; Sivasoorian SS; Yang JY; Wang LF
    ACS Appl Bio Mater; 2021 Apr; 4(4):3264-3275. PubMed ID: 35014413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polyacrylic acid modified upconversion nanoparticles for simultaneous pH-triggered drug delivery and release imaging.
    Jia X; Yin J; He D; He X; Wang K; Chen M; Li Y
    J Biomed Nanotechnol; 2013 Dec; 9(12):2063-72. PubMed ID: 24266261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Visible light-triggered nitric oxide release from near-infrared fluorescent nanospheric vehicles.
    Tan L; Wan A; Zhu X; Li H
    Analyst; 2014 Jul; 139(13):3398-406. PubMed ID: 24828458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. pH-triggered chitosan nanogels via an ortho ester-based linkage for efficient chemotherapy.
    Yang G; Wang X; Fu S; Tang R; Wang J
    Acta Biomater; 2017 Sep; 60():232-243. PubMed ID: 28479490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Redox and pH dual-responsive PEG and chitosan-conjugated hollow mesoporous silica for controlled drug release.
    Jiao J; Li X; Zhang S; Liu J; Di D; Zhang Y; Zhao Q; Wang S
    Mater Sci Eng C Mater Biol Appl; 2016 Oct; 67():26-33. PubMed ID: 27287095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of cytotoxicity profile and intracellular localisation of doxorubicin-loaded chitosan nanoparticles.
    Souto GD; Farhane Z; Casey A; Efeoglu E; McIntyre J; Byrne HJ
    Anal Bioanal Chem; 2016 Aug; 408(20):5443-55. PubMed ID: 27225177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Redox-responsive mesoporous selenium delivery of doxorubicin targets MCF-7 cells and synergistically enhances its anti-tumor activity.
    Zhao S; Yu Q; Pan J; Zhou Y; Cao C; Ouyang JM; Liu J
    Acta Biomater; 2017 May; 54():294-306. PubMed ID: 28267598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer therapy and fluorescence imaging using the active release of doxorubicin from MSPs/Ni-LDH folate targeting nanoparticles.
    Li D; Zhang YT; Yu M; Guo J; Chaudhary D; Wang CC
    Biomaterials; 2013 Oct; 34(32):7913-22. PubMed ID: 23886730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combinatory Cancer Therapeutics with Nanoceria-Capped Mesoporous Silica Nanocarriers through pH-triggered Drug Release and Redox Activity.
    Singh RK; Patel KD; Mahapatra C; Parthiban SP; Kim TH; Kim HW
    ACS Appl Mater Interfaces; 2019 Jan; 11(1):288-299. PubMed ID: 30539634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Multifunctional Lipid Incorporating Active Targeting and Dual-Control Release Capabilities for Precision Drug Delivery.
    Liu C; Ewert KK; Yao W; Wang N; Li Y; Safinya CR; Qiao W
    ACS Appl Mater Interfaces; 2020 Jan; 12(1):70-85. PubMed ID: 31774266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multifunctional upconversion mesoporous silica nanostructures for dual modal imaging and in vivo drug delivery.
    Li C; Yang D; Ma P; Chen Y; Wu Y; Hou Z; Dai Y; Zhao J; Sui C; Lin J
    Small; 2013 Dec; 9(24):4150-9. PubMed ID: 23843254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phthalocyanine-Conjugated Upconversion NaYF
    Kostiv U; Patsula V; Noculak A; Podhorodecki A; Větvička D; Poučková P; Sedláková Z; Horák D
    ChemMedChem; 2017 Dec; 12(24):2066-2073. PubMed ID: 29105372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Poly(ionic liquid)-Gated CuCo
    Fan SY; Hao YN; Zhang WX; Kapasi A; Shu Y; Wang JH; Chen W
    ACS Appl Mater Interfaces; 2020 Feb; 12(8):9000-9007. PubMed ID: 32013385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.